Frontiers in Endocrinology (Dec 2023)

Alterations in cellular metabolism under different grades of glioma staging identified based on a multi-omics analysis strategy

  • Xianlei Yan,
  • Xianlei Yan,
  • Jinwei Li,
  • Yang Zhang,
  • Cong Liang,
  • Pengcheng Liang,
  • Tao Li,
  • Quan Liu,
  • Xuhui Hui

DOI
https://doi.org/10.3389/fendo.2023.1292944
Journal volume & issue
Vol. 14

Abstract

Read online

Glioma is a type of brain tumor closely related to abnormal cell metabolism. Firstly, multiple combinatorial sequencing studies have revealed this relationship. Genomic studies have identified gene mutations and gene expression disorders related to the development of gliomas, which affect cell metabolic pathways. In addition, transcriptome studies have revealed the genes and regulatory networks that regulate cell metabolism in glioma tissues. Metabonomics studies have shown that the metabolic pathway of glioma cells has changed, indicating their distinct energy and nutritional requirements. This paper focuses on the retrospective analysis of multiple groups combined with sequencing to analyze the changes in various metabolites during metabolism in patients with glioma. Finally, the changes in genes, regulatory networks, and metabolic pathways regulating cell metabolism in patients with glioma under different metabolic conditions were discussed. It is also proposed that multi-group metabolic analysis is expected to better understand the mechanism of abnormal metabolism of gliomas and provide more personalized methods and guidance for early diagnosis, treatment, and prognosis evaluation of gliomas.

Keywords